Skip to main content
Home
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
      • Specialties
        • Vaccines & Infectious Diseases
        • Ophthalmology
        • Clinical Neuroscience
        • Rare Disease
        • Cell & Gene Therapy
        • Government
      • Additional Specialties
        • Hematology
        • Oncology
        • Maternal & Child Health
        • Medical Devices
      • Clinical Services
        • Biostatistics
        • Clinical Data Management
        • Clinical Research Services
        • Clinical Trial Management
        • Global Regulatory Affairs
        • Pharmacovigilance & Medical Monitoring
    • Veridix - Tech & AI
      • eClinical Platform
        • EDC
        • Decentralized Clinical Trials
        • RTSM
        • eCOA / ePRO
      • AI Agents
        • Biostats and Analysis Agent
        • Data Management Agent
        • Document Authoring
      • GlobalTrace
      • Analytics & Reporting
        • Clinical Pipelines
        • VERA
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Locations
    • Contact Us

Breadcrumb

  1. Emmes Group

gp100 Peptide Vaccine and Interleukin-2 in Patients with Advanced Melanoma

Go back to Resources

gp100 Peptide Vaccine and Interleukin-2 in Patients with Advanced Melanoma

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

Good Outcome of Kidney Transplants in Recipients of Young Donors: A NAPRTCS Data Analysis

Go back to Resources

Good Outcome of Kidney Transplants in Recipients of Young Donors: A NAPRTCS Data Analysis

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

Foetal Antiepileptic Drug Exposure and Verbal Versus Non-Verbal Abilities at Three Years of Age

Go back to Resources

Foetal Antiepileptic Drug Exposure and Verbal Versus Non-Verbal Abilities at Three Years of Age

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

Dosing Strategies for Lithium Monotherapy in Children and Adolescents with Bipolar I Disorder

Go back to Resources

Dosing Strategies for Lithium Monotherapy in Children and Adolescents with Bipolar I Disorder

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

Cognitive Function at Age 6 Years in Children Exposed In Utero to Antiepileptic Drug

Go back to Resources

Cognitive Function at Age 6 Years in Children Exposed In Utero to Antiepileptic Drug

Authors:

Secondary:

Location:

URL:

Go back to Resources

Cognitive and Academic Outcomes after Pediatric Liver Transplantation: Functional Outcomes Group (FOG) Results

Go back to Resources

Cognitive and Academic Outcomes after Pediatric Liver Transplantation: Functional Outcomes Group (FOG) Results

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

Characteristics Associated With Severe Perineal and Cervical Lacerations During Vaginal Delivery

Go back to Resources

Characteristics Associated With Severe Perineal and Cervical Lacerations During Vaginal Delivery

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

Baseline Predictors of Visual Acuity and Retinal Thickness Outcomes in Patients with Retinal Vein Occlusion. SCORE Study Report 10

Go back to Resources

Baseline Predictors of Visual Acuity and Retinal Thickness Outcomes in Patients with Retinal Vein Occlusion. SCORE Study Report 10

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

A West Nile Virus DNA Vaccine Utilizing a Modified Promoter Induces Neutralizing Antibody in Younger and Older Healthy Adults in a Phase I Clinical Trial

Go back to Resources

A West Nile Virus DNA Vaccine Utilizing a Modified Promoter Induces Neutralizing Antibody in Younger and Older Healthy Adults in a Phase I Clinical Trial

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

A Web-Based Study Product Verification Utility for Blinded Treatment of Food Allergy Subjects

Go back to Resources

A Web-Based Study Product Verification Utility for Blinded Treatment of Food Allergy Subjects

Authors:

Secondary:

Location:

URL:

Go back to Resources

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 182
  • Page 183
  • Page 184
  • Page 185
  • Current page 186
  • Page 187
  • Page 188
  • Page 189
  • Page 190
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to
Emmes Group

Delivering Global Health
Impact Through People,
Science and Technology

Main navigation
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
    • Veridix - Tech & AI
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Locations
    • Contact Us

Copyright ©, The Emmes Company, LLC

Footer
  • Cookie Policy
  • External Privacy Notice
  • FCOI
  • Emmes EU-U.S. Data Privacy Framework
  • Purchasing Terms and Conditions